A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VIDANGADI NASYA AND GUDA NAGARA NASYA IN THE MANAGEMENT OF ARDHAVABHEDAKA W S R TO MIGRAINE

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017079

Enrollment

Registered

2019-01-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: NASYA NASAL ADMINISTRATION OF HERBAL MEDICINE: VIDANGADI NASYA 3 MUCHUTI PRAMANA FOR 7 DAYS Control Intervention1: GUDA NAGARA NASYA: GUDA NAGARA NASYA 6 DROPS FOR 7 DAYS FOR 20 PATIENT

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS HAVING LAKSHANAS OF ARDHAVABHEDAKA PATIENTS HAVING MINIMUM OF ONE MIGRAINE EPISODE IN A WEEK PATIENTS FIT FOR THE PROCEDURE OF NASYA KARMA PATIENTS BETWEEN 16 TO 60 YEARS OF EITHER SEX

Exclusion criteria

Exclusion criteria: PREVIOUSLY DIAGNOSED CASES OF HEADACHE DUE TO SECONDARY CAUSES WILL BE EXCLUDED PATIENTS WITH OTHER SYSTEMIC DISORDERS WHICH CAN INTERFERE WITH THE COURSE OF TREATMENT WILL BE EXCLUDED PATIENTS UNFIT FOR NASYA KARMA PATIENTS HAVING HISTORY OF HEAD INJURY

Design outcomes

Primary

Measure	Time frame
EFFICACY OF INTERVENTION OVER SUBJECTIVE CRITERIA OF ARDHAVABHEDAKATimepoint: At follow up on the 14th day	—

Secondary

Measure	Time frame
NILTimepoint: 7 DAYS	—

Countries

India

Contacts

Public ContactDR B A VENKATESH

SRI KALABYRAVESHWARA SWAMY AYURVEDIC MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE

dr.bavenkatesh@gmail.com9845015567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026